Fidelity Wise Origin Bitcoin Fund amends trust agreement to allow in-kind share transactions
Investing.com -- Vimian has acquired AllAccem Inc., a US-based veterinary dental care company with trailing twelve-month revenues of approximately $9 million as of April 2025 and an EBITDA margin exceeding the group average.
AllAccem has achieved strong double-digit growth, primarily driven by its flagship product SANOS, a dental sealant accepted by the Veterinary Oral Health Council (VOHC) that is widely used across veterinary clinics in the United States.
The strategic acquisition aligns with Vimian’s objective to expand its MedTech portfolio with high-growth, high-margin businesses operating in specialized segments of animal health. SANOS offers a recurring revenue profile, clinical validation, and holds a market leadership position in the consumables category.
Vimian intends to leverage the global commercial infrastructure of iM3, particularly in markets outside the United States, to accelerate AllAccem’s expansion. While the transaction is expected to have only a marginal impact on Vimian’s fiscal year 2025 earnings, it represents a strategic addition to the company’s offerings.
The acquisition will be financed through Vimian’s available cash resources, with the transaction expected to close on or around June 13, 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.